Author: admin

CAMBRIDGE, Mass., Oct. 17, 2024 /PRNewswire/ — Factor Bioscience Inc. (“Factor”) and Eterna Therapeutics Inc. (“Eterna”) today announced an exclusive license and collaboration agreement aimed at accelerating the development of advanced cell therapy candidates for oncolo

Magazine made for you.

Featured:

No posts were found for provided query parameters.

Elsewhere: